Supplemental material
Leukemia & Lymphoma
Volume 59, 2018 - Issue 8
Original Article: Clinical
Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations
, 
, , , , , , , , , , & show all
Igor AurerDepartment of Internal Medicine, University Hospital Centre Zagreb, Zagreb, Croatia; https://orcid.org/0000-0001-6175-4277
https://orcid.org/0000-0001-6175-4277, , , Georg HessUniversity Medical School of the Johannes Gutenberg-University, Mainz, Germany; https://orcid.org/0000-0002-9282-5688
https://orcid.org/0000-0002-9282-5688, Mats JerkemanDepartment of Oncology, Lund University, Lund, Sweden; https://orcid.org/0000-0003-4509-6707
https://orcid.org/0000-0003-4509-6707, Steven Le GouillCHU Nantes, Nantes, France; https://orcid.org/0000-0001-9840-2128
https://orcid.org/0000-0001-9840-2128, Vincent RibragInstitut Gustave Roussy, Villejuif, France; https://orcid.org/0000-0002-5221-353X
https://orcid.org/0000-0002-5221-353X, Marek TrněnýGeneral Hospital, Charles University, Praha, Czech Republic; https://orcid.org/0000-0002-6952-6073
https://orcid.org/0000-0002-6952-6073, Carlo ViscoSan Bortolo Hospital, Vicenza, Italy; https://orcid.org/0000-0002-6025-7313
https://orcid.org/0000-0002-6025-7313, , Francesco ZajaClinica Ematologica, Centro Trapianti e Terapie Cellulari “Carlo Melzi,” University of Udine, Udine, Italy; https://orcid.org/0000-0003-3995-8817
https://orcid.org/0000-0003-3995-8817 & Pier Luigi ZinzaniInstitute of Hematology “Seràgnoli,” University of Bologna, Bologna, Italyhttps://orcid.org/0000-0002-2112-2651
https://orcid.org/0000-0002-2112-2651 show all